|
CEST 11:00 – 13:00 hours
|
|
OPENING SESSION (HYBRID)
|
| Moderators |
Andrea Doria (Italy), Zahir Amoura (France)
|
| 11:30 |
Opening Remarks |
Andrea Doria (Italy)
|
| 11:40 |
Debate
Early biologic Treatment in Systemic Lupus: Necessary or Overemphasized?
The matter of the debate (10 minutes)
Necessary (25 minutes, including rebuttal)
Overemphasized (25 minutes including rebuttal)
|
Ricard Cervera (Spain)
Mariele Gatto (Italy)
Chris Wincup (UK)
|
| 12:40 |
Q&A and Panel Discussion (20 minutes)
|
|
| 13:00-13:30 |
Poster Tour 1 and Lunch
(Not part of the accredited CME programme)
|
Maria Dall’Era (USA)
|
|
add to calendar |
|
CEST 13:30–14:30 hours
|
|
1. INDUSTRY-SPONSORED SYMPOSIUM
|
| |
|
| 13:30-14:30 |
Bristol Myers Squibb
(Not part of the accredited CME programme)
|
TBC
|
| 14:30-15:00 |
Break
|
|
|
add to calendar |
|
CEST 15:00 – 17:00 hours
|
|
KEYNOTES: NEW CHALLENGES IN THE MANAGEMENT OF SLE (HYBRID)
|
| Moderators |
Ricard Cervera (Spain), Sandra Navarra (Philippines)
|
| 15:00 |
Health Inequalities in SLE: A Global Perspective
|
Sandra Navarra (Philippines)
|
| 15:20 |
Shared Decision Making in Lupus Care
|
Johanna Mucke (Germany)
|
| 15:40 |
What Defines Success in Lupus/Lupus Nephritis in 2026?
|
Richard Furie (USA)
|
| 16:00 |
How to Measure and Manage Cardiovascular Risk in SLE.
From Data to Daily Clinical Practice
|
Levy-Dan Azoulay (France)
|
| 16:20 |
Q&A and Panel Discussion (30 mins)
|
|
| 17:00-17:30 |
Break and Poster Tour 2
(Not part of the accredited CME programme)
|
Murray Urowitz (Canada)
|
|
add to calendar |
|
CEST 17:30–18:30 hours
|
|
2. INDUSTRY-SPONSORED SYMPOSIUM
|
| |
|
| 17:30-18:30 |
TBC
(Not part of the accredited CME programme)
|
TBC
|
| 19:00-20:30 |
Poster Viewing & Networking Walking Dinner
(Not part of the accredited CME programme)
|
|
|
add to calendar |
|
CEST 08:00–09:00 hours
|
|
3. INDUSTRY-SPONSORED SYMPOSIUM
|
| |
|
| 08:00-09:00 |
TBC
(Not part of the accredited CME programme)
|
TBC
|
|
add to calendar |
|
CEST 09:30 – 11:00 hours
|
|
CASE STUDY WORKSHOPS
|
| Moderator |
Murray Urowitz (Canada)
|
| 9:30 |
Managing Transitions: Pediatric and Adolescent Lupus
|
Patricia Costa Reis (Portugal) &
Coziana Ciurtin (UK)
|
| Moderator |
Richard Furie (USA)
|
| 9:30 |
Managing Lupus Nephritis
|
Maria Dall’Era (USA) &
Onno Teng (Netherlands)
|
| Moderator |
Andrea Doria (Italy)
|
| 9:30 |
Managing Skin Lupus
|
Annegret Kuhn (Germany) &
Filippa Nyberg (Sweden)
|
| Moderator |
Zahir Amoura (France)
|
| 9:30 |
Managing Antiphospholipid Syndrome
|
Denis Wahl (France) &
Ricard Cervera (Spain)
|
| Moderator |
David Isenberg (UK)
|
| 9:30 |
Challenging Lupus: Multidisciplinary Perspectives
|
TBC &
Sandra Navarra (Philippines)
|
|
add to calendar |
|
CEST 11:00 – 12:30 hours
|
|
PLENARY I: TARGETED THERAPIES (HYBRID)
|
| Moderators |
Murray Urowitz (Canada); Ricard Cervera (Spain)
|
| 11:00 |
Biologics: From RCTs to Clinical Practice
|
Ronald Van Vollenhoven (Netherlands)
|
| 11:20 |
Small Molecules: New Players
|
David Isenberg (UK)
|
| 11:40 |
CAR-T: 5 Years of Clinical Experience
|
TBC
|
| 12:00 |
Q&A and Panel Discussion (30 minutes)
|
|
| 10:00 |
Break and Poster Tour 4
(Not part of the accredited CME programme)
|
Sandra Navarra (Philippines)
|
|
add to calendar |
|
CEST 13:00-14:00 hours
|
|
4. INDUSTRY-SPONSORED SYMPOSIUM
|
| |
|
| 13:00-14:00 |
AstraZeneca
(Not part of the accredited CME programme)
|
TBC
|
| 14:00-14:30 |
Break and Poster Tour 3
(Not part of the accredited CME programme)
|
Ronald Van Vollenhoven (Netherlands)
|
| 14:00-14:30 |
Fishbowl Cases
(Not part of the accredited CME programme)
|
Richard Furie (USA) &
Sandra Navarra (Philippines)
|
|
add to calendar |
|
CEST 14:30 – 16:00 hours
|
|
PLENARY II: NEW PERSEPCTIVES ON LUPUS MANAGEMENT (HYBRID)
|
| Moderators |
Ronald Van Vollenhoven (Netherlands); Andrea Doria (Italy)
|
| 14:30 |
SLE and Flare Prevention: Physician and Patient Collaborations
|
Luis Inês (Portugal)
|
| 14:50 |
The Patient Pathway: From Disease Activity to Deep Remission
|
Luca Iaccarino (Italy)
|
| 15:10 |
Determinants of Disease Severity and Treatment Resistance in SLE
|
George Bertsias (Greece)
|
| 15:30 |
Artificial Intelligence and SLE
|
Vincenzo Venerito (Italy)
|
| 15:50 |
Q&A and Panel Discussion (20 mins)
|
|
| 16:00 |
Break
|
|
|
add to calendar |
|
CEST 16:30 – 18:00 hours
|
|
CASE STUDY WORKSHOPS
|
| Moderator |
Murray Urowitz (Canada)
|
| 16:30 |
Managing Transitions: Pediatric and Adolescent Lupus
|
Patricia Costa Reis (Portugal) &
Ciurtin Coziana (UK)
|
| Moderator |
Richard Furie (USA)
|
| 16:30 |
Managing Lupus Nephritis
|
Maria Dall’Era (USA) &
Onno Teng (Netherlands)
|
| Moderator |
Andrea Doria (Italy)
|
| 16:30 |
Managing Skin Lupus
|
Annegret Kuhn (Germany) &
Filippa Nyberg (Sweden)
|
| Moderator |
Zahir Amoura (France)
|
| 16:30 |
Managing Antiphospholipid Syndrome
|
Denis Wahl (France) &
Ricard Cervera (Spain)
|
| Moderator |
David Isenberg (UK)
|
| 16:30 |
Challenging Lupus: Multidisciplinary Perspectives
|
TBC &
Sandra Navarra (Philippines)
|
| 18:00 |
Session Close
|
|
|
add to calendar |
|
CEST 08:30 – 10:00 hours
|
|
PLENARY III: LUPUS PATHOGENESIS (HYBRID)
|
| Moderators |
David Isenberg (UK), Maria Dall’Era (USA)
|
| 08:30 |
Signatures in SLE: What Omics is Teaching Us About Disease Mechanisms
|
Ioannis Parodis (Sweden)
|
| 08:50 |
Urinary Biomarkers in Lupus Nephritis
|
Andrea Fava (USA)
|
| 09:10 |
Defining Immune Reset in SLE
|
Thomas Dörner (Germany)
|
| 09:30 |
Q&A and Panel Discussion (30 mins)
|
|
| 10:00 |
Break
|
|
|
add to calendar |
|
CEST 10:30-11:30 hours
|
|
5. INDUSTRY-SPONSORED SYMPOSIUM
|
| |
|
| 10:30-11:30 |
TBC
(Not part of the accredited CME programme)
|
TBC
|
| 11:30-12:00 |
Break
|
|
|
add to calendar |
|
CEST 12:00-14:00 hours
|
|
POST MEETING COURSE (NO SEPARATE FEE REQUIRED): SJÖGREN'S (HYBRID)
|
| |
Thomas Dörner (Germany
|
| 12:30 |
Clinical Presentations: Diagnostics and Management Approaches
|
Chiara Baldini (Italy)
|
| 12:55 |
Clinical Trials: Improving Design and Execution
|
Antonia Szántó (Hungary)
|
| 13:20 |
Targeted Therapies: B-cells, MAbs, anti-CD40 and JaKs
|
David Isenberg (UK)
|
| 13:45 |
Anti-Baff Receptor (ianalumab) in Sjögrens
|
Thomas Dörner (Germany)
|
| 14:10 |
Q&A and Panel Discussion (20 minutes)
|
|
| 14:30 |
Meeting Close
|
|
|
add to calendar |
